[对于谁,如何和为什么目的 - 结直肠癌的新辅助疗法?]
Franziska Willis1, Thilo Schwandner2, Martin Reichert1
1Abteilung für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie, Universitätsklinikum Gießen und Marburg, Standort Gießen, Gießen, Deutschland.
Zentralblatt fur Chirurgie
|April 8, 2025
概括
新辅助疗法改善了直肠癌的治疗结果. 研究正在探索全新辅助疗法 (TNT) 和器官保存策略,以进一步优化基于癌症阶段的个性化治疗.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 结直肠癌的治疗已经进步,减少了局部复发,改善了预后.
- 目前德国的指导方针建议针对中下直肠瘤的特定阶段 (UICC II/III) 进行新辅助疗法.
- 初级手术仍然是UICC I的标准,针对特定子组的讨论正在进行中.
研究的目的:
- 为提供关于直肠癌的新辅助治疗现有证据的全面审查.
- 突出新的多模式治疗方法,包括全新辅助疗法 (TNT).
- 讨论未来的挑战和优化特定阶段,个性化直肠癌护理的机会.
主要方法:
- 审查关于直肠癌新辅助治疗策略的当前证据.
- 来自研究全新辅助疗法 (TNT) 的II期和III期试验数据的分析.
- 检查新兴概念,如选择性省略新辅助放射治疗和器官保存方法.
主要成果:
- 新辅助疗法显著降低了局部复发率,改善了直肠癌的预后.
- 总的新辅助疗法 (TNT) 是正在进行的临床试验中的一个关键重点,显示了前景.
- 研究方法包括省略新辅助放射治疗和探索器官保存手术选择.
结论:
- 新辅助疗法对于改善直肠癌的结果至关重要,特别是在UICCII和III阶段.
- 总的新辅助疗法 (TNT) 和器官保存策略代表了有希望的未来方向.
- 通过针对个体患者和瘤特征的多式疗法优化治疗对于推进直肠癌护理至关重要.
更多相关视频
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


